Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
| $38.1M | ﹤0.01% |
3,406,674
+133,612
| +4% | +$1.46M |
|
2177
Pathward Financial
CASH
$1.86B
| $38M | ﹤0.01% |
480,855
+59,150
| +14% | +$4.53M |
|
2178
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.26B
| $38M | ﹤0.01% |
477,715
-5,460
| -1% | -$392K |
|
2179
Corebridge Financial
CRBG
$14.1B
| $37.9M | ﹤0.01% |
1,067,036
-144,144
| -12% | -$4.48M |
|
|
ASA
2180
ASA Gold and Precious Metals
ASA
$919M
| $37.8M | ﹤0.01% |
1,197,203
-160,847
| -12% | -$4.91M |
|
2181
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$401M
| $37.8M | ﹤0.01% |
567,210
+50,272
| +10% | +$3.27M |
|
2182
SiriusPoint
SPNT
$2.75B
| $37.7M | ﹤0.01% |
1,848,704
+250,595
| +16% | +$4.61M |
|
2183
WisdomTree Managed Futures Strategy Fund
WTMF
$245M
| $37.3M | ﹤0.01% |
1,057,295
+41,766
| +4% | +$1.44M |
|
2184
Burford Capital
BUR
$903M
| $37.3M | ﹤0.01% |
2,614,779
-26,100
| -1% | -$341K |
|
2185
iShares North American Natural Resources ETF
IGE
$741M
| $37.3M | ﹤0.01% |
841,929
-69,382
| -8% | -$2.97M |
|
|
CHW
2186
Calamos Global Dynamic Income Fund
CHW
$530M
| $37.3M | ﹤0.01% |
5,224,474
+204,503
| +4% | +$1.34M |
|
2187
Haemonetics
HAE
$3.89B
| $37.2M | ﹤0.01% |
498,049
+66,453
| +15% | +$4.4M |
|
2188
Schwab Fundamental US Small Company Index ETF
FNDA
$9.12B
| $37.2M | ﹤0.01% |
1,296,735
-17,262
| -1% | -$468K |
|
2189
CEVA Inc
CEVA
$910M
| $37.1M | ﹤0.01% |
1,690,033
+656,392
| +64% | +$14.6M |
|
2190
State Street SPDR ICE Preferred Securities ETF
PSK
$692M
| $37.1M | ﹤0.01% |
1,168,821
-196,623
| -14% | -$6.22M |
|
2191
Kilroy Realty
KRC
$4.52B
| $37.1M | ﹤0.01% |
1,081,552
+268,630
| +33% | +$8.76M |
|
2192
Adient
ADNT
$1.65B
| $37M | ﹤0.01% |
1,902,709
+473,503
| +33% | +$7M |
|
2193
WisdomTree US SmallCap Earnings Fund
EES
$719M
| $37M | ﹤0.01% |
726,470
-23,482
| -3% | -$1.13M |
|
2194
Vital Farms
VITL
$545M
| $37M | ﹤0.01% |
960,718
-1,212
| -0.1% | -$40.9K |
|
|
AKRO
2195
DELISTED
Akero Therapeutics
AKRO
| $37M | ﹤0.01% |
693,256
-109,598
| -14% | -$4.98M |
|
2196
Pagaya Technologies
PGY
$1.61B
| $37M | ﹤0.01% |
1,734,995
+1,127,590
| +186% | +$16M |
|
2197
Immunovant
IMVT
$7.93B
| $36.9M | ﹤0.01% |
2,309,061
+999,011
| +76% | +$15.1M |
|
2198
Cytokinetics
CYTK
$10.5B
| $36.9M | ﹤0.01% |
1,118,080
+106,335
| +11% | +$3.7M |
|
2199
Invesco S&P MidCap Low Volatility ETF
XMLV
$750M
| $36.9M | ﹤0.01% |
597,901
+8,004
| +1% | +$486K |
|
|
SLNO
2200
DELISTED
Soleno Therapeutics
SLNO
| $36.9M | ﹤0.01% |
440,054
+227,695
| +107% | +$17M |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.